Skip to main content

Advertisement

Log in

Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF)

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

We aimed to validate a severity grading score (SGS) system for predicting the course of disease and fatality in Crimean-Congo hemorrhagic fever (CCHF). This SGS was established using several variables that were assumed to be associated with mortality and had clinical importance. We included patients diagnosed with CCHF from different centers. Patients who had symptoms of CCHF for <5 days were included. The patients were grouped into three categories according to mortality risk. An SGS ≤4 showed no association with mortality [n = 323 (79.9 % of the total study population), and all survived]. An SGS between 5 and 8 points was classified into the intermediate risk group (20 %), and 14 of 70 patients in this group died. An SGS ≥9 was classified as the high risk of mortality group and 11 of 11 patients in this group died (p = 0.001). The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value for an SGS >9 points at admission were 96, 100, 97, 100, and 44 %, respectively. This SGS system may help appropriate the triage of patients, decrease the cost of treatment, and improve the functionality of healthcare staff. The present study is the first investigation about the validation of an SGS system in patients with CCHF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ergönül O (2006) Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6:203–214

    Article  PubMed  Google Scholar 

  2. The Turkish Medical Association Publications (Türk Tabipleri Birligi Yayinlari) (2011) Scientific assessment report of the Crimean-Congo haemorrhagic fever. Available online at: http://www.ttb.org.tr/kutuphane/kirim_kongo_rpr.pdf. Accessed 17 July 2014

  3. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B (2006) Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 12:551–554

    Article  CAS  PubMed  Google Scholar 

  4. Koksal I, Yilmaz G, Aksoy F, Aydin H, Yavuz I, Iskender S, Akcay K, Erensoy S, Caylan R, Aydin K (2010) The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol 47:65–68

    Article  CAS  PubMed  Google Scholar 

  5. Keshtkar-Jahromi M, Kuhn JH, Christova I, Bradfute SB, Jahrling PB, Bavari S (2011) Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Antiviral Res 90:85–92

    Article  CAS  PubMed  Google Scholar 

  6. Bakir M, Engin A, Gozel MG, Elaldi N, Kilickap S, Cinar Z (2012) A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis 49:105–110

    PubMed  Google Scholar 

  7. Whitehouse CA (2004) Crimean-Congo hemorrhagic fever. Antiviral Res 64:145–160

    Article  CAS  PubMed  Google Scholar 

  8. Cevik MA, Erbay A, Bodur H, Gülderen E, Baştuğ A, Kubar A, Akinci E (2008) Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 12:374–379

    Article  PubMed  Google Scholar 

  9. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S (1989) The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 11:S794–S800

    Article  PubMed  Google Scholar 

  10. Yilmaz G, Koksal I, Topbas M, Yilmaz H, Aksoy F (2010) The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. J Clin Virol 47:361–365

    Article  PubMed  Google Scholar 

  11. Tasdelen Fisgin N, Tanyel E, Doganci L, Tulek N (2009) Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever. Trop Doct 39:158–160

    Article  PubMed  Google Scholar 

  12. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H; Turkish CCHF Study Group (2005) Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 54:385–389

    Article  PubMed  Google Scholar 

  13. Onguru P, Dagdas S, Bodur H, Yilmaz M, Akinci E, Eren S, Özet G (2010) Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J Clin Lab Anal 24:163–166

    Article  CAS  PubMed  Google Scholar 

  14. Hatipoglu CA, Bulut C, Yetkin MA, Ertem GT, Erdinc FS, Kilic EK, Sari T, Kinikli S, Oral B, Demiroz AP (2010) Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey. Scand J Infect Dis 42:516–521

    Article  CAS  PubMed  Google Scholar 

  15. Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, Gundogdu M, Tasyaran MA (2006) Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 52:207–215

    Article  PubMed  Google Scholar 

  16. Dokuzoguz B, Celikbas AK, Gök ŞE, Baykam N, Eroglu MN, Ergönül Ö (2013) Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality. Clin Infect Dis 57:1270–1274

    Article  CAS  PubMed  Google Scholar 

  17. Cevik MA, Erbay A, Bodur H, Eren SS, Akinci E, Sener K, Ongürü P, Kubar A (2007) Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis 45(7):e96–e100

    Article  PubMed  Google Scholar 

  18. Wölfel R, Paweska JT, Petersen N, Grobbelaar AA, Leman PA, Hewson R, Georges-Courbot MC, Papa A, Günther S, Drosten C (2007) Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis 13(7):1097–100

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the Refik Saydam Hygiene Center of Ankara, Turkey for testing the serum samples.

Ethical approval

The study was approved by the Medical Ethics Committee of the Cumhuriyet University School of Medicine.

Funding

None.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Bakır.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bakır, M., Gözel, M.G., Köksal, İ. et al. Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF). Eur J Clin Microbiol Infect Dis 34, 325–330 (2015). https://doi.org/10.1007/s10096-014-2238-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-014-2238-0

Keywords

Navigation